Psychotropic drugs in nursing- and old-age homes: Relationships between needs of care and mental health status

European Journal of Clinical Pharmacology

Volumn 59, Issue 8-9, 2003, Pages 669-676

  Holmquist, Ing Britt ^a   Svensson, Bengt ^a   Höglund, Peter ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Elderly; Nursing home; Old age homes

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGE; AGED; ARTICLE; DEMENTIA; DEPRESSION; DRUG EFFECT; DRUG INDICATION; DRUG USE; FEMALE; GENDER; HEALTH CARE NEED; HEALTH STATUS; HOME FOR THE AGED; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NURSING HOME; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SWEDEN;

AGED; AGED, 80 AND OVER; ANXIETY; ANXIETY DISORDERS; DEPRESSION; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SLEEP DISORDERS;

EID: 0344303610     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0679-y     Document Type: Article

References (49)

1. SCB (2001) Sweden's official statistics, statistical announcements BE 12 SM 0101. Population of the whole country, the counties and the municipalities 31 December 2000 (in Swedish). Statistiska Centralbyrån, Stockholm
2. Fastbom J, Claesson CB, Cornelius C, Thorslund M, Winblad B (1995) The use of medicines with anticholinergic effects in older people. J Am Geriatr Soc 43:1135-1140
3. Burns A (1997) Psychiatric symptoms and behavioural disturbances in the dementias. J Neural Transm 51:27-35
4. Elmståhl S, Stenberg I, Annerstedt, L, Ingvad B (1998) Behavioural disturbances and pharmacological treatment of patients with dementia in family care giving: a 2-year follow up. Int Psychogeriatr 10:239-252
5. Thacker S, Jones R (1997) Neuroleptic prescribing to the community elderly in Nottingham. Int J Geriatr Psychiatry 12:833-837
6. Furniss L, Lloyd Craig SK, Burns A (1998) Review: medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433-439
7. Schmidt I, Claesson C, Westerholm B, Svarstad BL (1998) Resident characteristics and organizational factors influencing the quality of drug use in Sweden nursing homes. Soc Sci Med 47:961-971
8. Schjott J, Opedal K, Rutledal JE (1999) A survey of hypnotic use in geriatric institutions in Sogn og Fjordane, Norway. Aging Clin Exp Res 11:50-55
9. Williams BR, Nichol MB, Lowe B, Yoon PS, McCombs JS, Margolies J (1999) Medication use in residential care facilities for the elderly. Ann Pharmacother 33:149-155
10. Ruths S, Straand J, Nygaard HA (2001) Psychotropic drug use in nursing homes-diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57:523-528
11. Sörensen L, Foldspang A, Gulmann NC, Munk-Jörgensen P (2001) Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16:147-154
12. Katona C (2001) Psychotropics and drug interactions in the elderly patient. Int J Geriatr Psychiatry 16:86-90
13. Fastbom J (2001) Elderly and drugs. Liber, Stockholm
14. Beers MH (1997) Explicit criteria for determining inappropriate medication use by the elderly: an update. Arch Intern Med 157:1531-1536
15. Steffens DC, Krishnan KRR (1998) Metabolism, bioavailability and drug interactions. Clin Geriatr Med 14:17-31
16. Cooper JW (1996) Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc 44:194-197
17. Turnheim K (1998) Drug dosage in the elderly. Is it rational? Drugs Aging 13:357-379
18. Atkin PA, Veitch PC, Veitch EM, Ogle SJ (1999) The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 14:41-52
19. Meador KJ (1998) Cognitive side effects of medication. Neurol Clin 16:141-155
20. Moore AR, O'Keeffe ST (1999) Drug-induced cognitive impairment. Drugs Aging 15:15-28
21. Mustard CA, Mayer T (1997) Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol 145:738-745
22. Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875-882
23. Monane M, Glynn RJ, Avorn J (1996) The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther 59:83-92
24. Ersser S, Wiles A, Taylor H, Wade S, Walsh R, Bentey T (1999) The sleep of older people in hospital and nursing homes. J Clin Nurs 8:360-368
25. Opedal K, Schjott J, Eide E (1998) Use of hypnotics among patients in geriatric institutions. Int J Geriatr Psychiatry 13:846-851
26. Evans DL, Staab JP, Petitto JM, et al (1999) Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60:40-55
27. Henderson AS, Korten AE, Jorm AF, et al (1994) Are nursing homes depressing? Lancet 344:1091
28. Arthur A, Matthews R, Jagger C, Lindesay J (2002) Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 17:54-60
29. Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in the development of an index of ADL. Gerontologist 10:20-30
30. 30: Katz S, Ford AB, Moskowits RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919
31. Brorsson B, Hulter Åsberg K (1984) Katz index of independence in ADL: reliability and validity in short-term care. Scand J Rehabil Med 16:125-132
32. Jensen E, Dehlin O, Gustafson G (1993) A comparison between three psychogeriatric rating scales. Int J Geriatr Psychiatry 8:215-229
33. WHO Collaborating Centre for Drugs Statistics and Methodology (2000) Anatomical therapeutic chemical (ATC) classification index. World Health Organisation, Oslo
34. The National Board of Health and Welfare (1997) International classification of diseases and related health problems, tenth revision (ICD-10). Stockholm
35. SPSS (1993) Base system users guide. SPSS, Inc., Chicago
36. The National Board of Health and Welfare (1998) Ädelparadoxen: sjukhemmen före och efter Ädelreformen (in Swedish). Stockholm
37. Isacsson G (2000) Suicide prevention - a medical breakthrough? Acta Psychiatr Scand 102:113-117
38. Lasser RA, Sunderland T (1998) Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 46:202-207
39. Brorson S, Scanlan JM, Doane K, Gray S (2002) Antidepressant prescribing in nursing homes: is there a place for tricyclics? Int J Geriatr Psychiatry 17:1140-1145
40. Roberts MS, King M, Stokes JA, et al (1998) Medication prescribing and administration in nursing homes. Age Ageing 27:385-392
41. Newman SC, Hassan AI (1999) Antidepressant use in the elderly population in Canada: results from a national survey. J Gerontol A Biol Sci Med Sci 54:527-530
42. Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips C (2000) Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 29:165-172
43. Lader M (1997) Hypnotics in the elderly. Int J Geriatr Psychopharmacol 1:10-14
44. Bachman DL (1992) Sleep disorders with aging: evaluation and treatment. Geriatrics 47:53-61
45. Kennedy MM, Mion LC (1996) Neuroleptic therapy: how much do nurses know? J Gerontol Nurs 22:7-13
46. Elon R, Pawlson LG (1992) The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc 40:958-963
47. Miller SW (1993) Cost savings and reduction of medication related problems as a result of consultant pharmacy. Clin Pharm 8:1265-1271
48. Kane R, Garrard J (1994) Changing physician prescribing practices: regulation vs education. JAMA 271:393-394
49. Avorn J, Soumerai SB, Everitt DE, et al (1992) A randomized trial of program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 327:168-173